THOUGHT LEADERSHIP
From Roadblocks to Runways: Aligning Services for a Smooth Patient Journey
COMMERCIAL PLANNING
Gain the tools needed to clear the runway for your next launch, enhance program performance, and deliver a more coordinated, patient-centered journey.
Revolutionizing Patient Care: The Top Five Benefits of Investing in Innovation
ACCESS AND AFFORDABILITY
How prioritizing innovation can optimize patient outcomes and secure a competitive advantage in the pharma industry
Fair Market Value vs. Current Market Leverage in Negotiations
DISTRIBUTION
How pharma should consider their FMV cost assessment compared to their negotiation leverage when contracting for services
Managing Your Network:
Are Your Specialty Pharmacies Meeting Program Expectations
Are Your Specialty Pharmacies Meeting Program Expectations
PHARMACY
Specialty Pharmacy Performance Assessment: Four Best Practices to Maintain a Successful Pharma Program
Distribution Decoded:
A Must-Have Reference Guide for Manufacturers
A Must-Have Reference Guide for Manufacturers
DISTRIBUTION
How Archbow can support your Trade Team with a customized reference guide to keep you competitive in the market.
Oncology and Vertically Integrated Supply Channels
DISTRIBUTION
A look into the critical factors of complex supply channels and the opportunities within these channels to support oncology drug programs.
Reimbursement Blueprint: A 4-Guide to a Successful Hub
ACCESS AND AFFORDABILITY
Webinar Archive: Four essential steps to creating a patient support HUB that meets the unique needs of a manufacturer’s patients and prescribers.
Best Practices to Optimize Strategic Partnerships
ACCESS AND AFFORDABILITY
The key to optimizing strategic pharma partnerships to improve quality, manage costs, and enhance patient outcomes.
A Must-Have Contracting Guide for Specialty Pharmacy Services
PHARMACY
Risk vs. Reward: Archbow Consulting experts detail four essential contracting best practices for achieving financial savings and long-term protection.
Does an Effective Alternative Distribution Model Really Exist?
DISTRIBUTION
The critical factors at play that manufacturers need to know as they consider pivoting to an Alternative Distribution Model.
Best Practices for Vendor Selection and Management
ACCESS AND AFFORDABILITY
The key to successfully selecting and managing the right commercial partners for your product and organizational needs.
11 Market Access Questions to Address for Specialty Drugs
DISTRIBUTION
Webinar Archive: How to get answers to the eleven key questions that will help guide commercial teams in effectively launching specialty products.
Best Practices for Improving SP Program Performance
PHARMACY
Best practices, lessons learned, and real-world insights gained from assisting multiple manufacturers improve their specialty pharmacy network performance.
10 Steps to Building and Integrated Launch Strategy
ACCESS AND AFFORDABILITY
The key to successfully building an integrated model for new products is understanding which steps in launch planning are essential and when to take them.
How to Prepare for DSCSA D-Day
DISTRIBUTION
The key to successfully building an integrated model for new products is understanding which steps in launch planning are essential and when to take them.
Effective And Practical Ways To Impact Health Inequity Now
COMMERCIAL PLANNING
Practical lists of questions spanning distribution, access, and affordability that Market Access teams can use to begin impacting health inequity today.
How To Maximize Relationships With Distribution Partners
DISTRIBUTION
Trade and distribution teams are facing more pressure than ever to leverage essential distribution and dispensing partnerships.
5 Hurdles To Patient Support Program Success
ACCESS AND AFFORDABILITY
Review common barriers to program success and explore ways to better design patient support programs that actually drive product access.
How Healthy Are Your Market Access Programs?
COMMERCIAL PLANNING
This whitepaper is a guide for market access teams to perform check-ups on the programs that can most impact product success.
6 Market Access Mistakes Cell & Gene Therapy Companies Make
COMMERCIAL PLANNING
Bringing CGTs to market was never going to be easy, but there’s no reason to repeat these common market access mistakes.
6 Strategies For Optimizing Cross-Functional Collaboration
ACCESS AND AFFORDABILITY
By following the 6 strategies in this whitepaper, pharma companies can improve collaboration and the overall patient journey
How CGT Companies Can Adapt in an Evolving Landscape
COMMERCIAL PLANNING
Cell and Gene Therapy manufacturers can make changes now, regarless of clinical trial phase, that will better prepare products for commercial success
2021 Health System Specialty Pharmacy Trend Report
PHARMACY
Actionable insights that create opportunities for greater collaboration between HSSPs, payers, and pharmaceutical manufacturers.
What You Need to Know about Drug Supply Chain Security Act
DISTRIBUTION
As November 2023 nears, it is essential for all manufacturers to understand the requirements to comply with the Drug Supply Chain Security Act
Navigating HUB Design In 2020
Webinar Archive
Webinar Archive
ACCESS AND AFFORDABILITY
In today’s marketplace, providing patient support services via a HUB is a market access reality for virtually all specialty products.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|